Fifty 410 vs Noom Med

Both sell tirzepatide. Fifty 410 costs $133 a month and Noom Med costs $149, a difference of $16 a month or about $192 a year. The other differences matter more than the money if this is your first course.

Fifty 410 is prepaid blocks with no subscription. Noom Med is behaviour change alongside medication. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.

What this means for your titration. Both price the same way as your dose climbs, so the gap between them stays constant the whole way up the ladder.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The differences that affect treatment

They differ on 2 of the 7 things we track, and behave the same on the other 5. The differences are what the price gap is actually buying.

What each programme publishes: Fifty 410

• Compounded tirzepatide starter protocol at $133/month, sold as a $399 three-month block.
• High-dose tirzepatide protocol at $183/month, sold as a $549 three-month block.
• No membership, no subscription and no recurring charges — you buy a block outright.
• Provider consultation and free 1-2 day shipping included in the price.
• States it is a telehealth platform that does not compound or distribute medication itself, and that preparations come from FDA-registered 503A pharmacies.
• Publishes unusually detailed information on 503A standards, USP 797 sterility and batch testing.
• No payment taken unless a provider approves you.

Where it wins: Genuinely no subscription — you buy a block and nothing recurs. Watch for: The $133 is the starter protocol. Moving to the high-dose protocol takes it to $183/month, and both are prepaid three-month commitments.

What each programme publishes: Noom Med

• Noom Med listed from $149/month.
• Microdose GLP-1Rx programme listed from $79/month with medication included.
• Programme pairs low-dose medication with biomarker monitoring and coaching.

Where it wins: The coaching is the actual product here and it is well built. Watch for: A $79 microdose programme is not the same treatment as 10 mg tirzepatide. Check the dose before comparing on price.

Strengths of each

Fifty 410.

• Genuinely no subscription — you buy a block and nothing recurs.
• Among the lowest tirzepatide rates verified.
• Unusually detailed public explanation of 503A standards and batch testing.

Noom Med.

• The coaching is the actual product here and it is well built.
• Medication is included in the microdose tier rather than billed separately.
• Straightforward cancellation.

How they score

Fifty 410 scores higher overall at 4.2 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

Which suits you

• Pick Fifty 410 if cost is the binding constraint. Over a year the gap is about $192, which is real money for the same class of medication.
• Pick Noom Med if what it does better matters to you — the coaching is the actual product here and it is well built.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

For most people starting out, Fifty 410 at $133 a month is the more defensible choice on arithmetic alone. Noom Med earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Fifty 410 and Noom Med.

How they sit against everyone else